Skip to main content

Table 3 Mean costs (in USD) per month by phase of treatment and average phase durations (in months)

From: Cost of treatment support for multidrug-resistant tuberculosis using patient-centred approaches in Ethiopia: a model-based method

 

Treatment state

 

1

2

3

4

5

6

7

8

IP in hospital

IP at home

IP SAE in hospital

IP SAE home

Extended IP

Extended IP and SAE

CP at home

CP SAE in hospital

Standard-of-care

        

 Health system

755.2

368.8

770.6

770.6

368.8

770.6

169.8

571.6

 Patient

134.4

31.0

134.4

134.4

31.0

134.4

31.0

134.4

 Patient with guardian

134.4

57.3

134.4

134.4

57.3

134.4

43.1

134.4

 Time spent in state

1.607

2.254

0.026

0.018

0.128

0.003

5.216

0.041

Patient-centred with weekly/daily DOT visits

        

 Health system

0

397.8/411.0

0

798.5

397.8/411.0

798.5

198.8/212.0

599.5

 Patient

0

6.6

0

134.4

6.6

134.4

6.6

134.4

 Patient with guardian

0

7.3

0

134.4

7.3

134.4

6.6

134.4

Hybrid with weekly/daily DOT visits

        

 Health system

0

396.7

0

798.5

396.7

798.5

198.8/212.0

599.5

 Patient

0

31.0

0

134.4

59.0

134.4

32.6

134.4

 Patient with guardian

0

45.3

0

134.4

73.3

134.4

32.6

134.4

 Time spent in state

0

3.858

0

0.055

0.145

0.003

5.198

0.042

  1. IP intensive phase, CP continuation phase, SAE serious adverse events, DOT directly-observed treatment